Listen "🎙️ Episode 34: MS Meds After 55? Time for a Pause ?"
Episode Synopsis
Send us a text🧪 Study:Patients ≥55 with no relapses in 5 yrs and no new lesions in 3 yrs may stop disease-modifying therapy (DMT).No significant difference in disability progression.🧩 Clinical Takeaway:De-escalation strategy in stable MS may reduce cost and side effects.Still requires close neurology follow-up.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.